CBP/p300-IN-14
Product Specifications
UNSPSC Description
CBP/p300-IN-14 is a potent inhibitor of CBP/EP300 (lysine acetyltransferase) with an IC50 of 3.3 nM (extracted from patent WO2021213521A1, compound 27)[1].
Target Antigen
Epigenetic Reader Domain; Histone Acetyltransferase
Type
Reference compound
Related Pathways
Epigenetics
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cbp-p300-in-14.html
Solubility
10 mM in DMSO
Smiles
O=C(C1=CC2=C(C=CC(N3C(CN(CC3)C)=O)=C2)C(N4C5=C(CCC4)C=C(C6=CN(C)N=C6)C(C(F)F)=C5)=N1)NC
Molecular Weight
559.61
References & Citations
[1]Wang, Lisha, et al. Cbp/ep300 inhibitor and use thereof. Patent WO2021213521A1.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-139861/CBP-p300-IN-14-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-139861/
Clinical Information
No Development Reported
CAS Number
2725036-10-0
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
